PortfoliosLab logoPortfoliosLab logo
WBIO.L vs. BTEC.L
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

WBIO.L vs. BTEC.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in WisdomTree BioRevolution UCITS ETF USD Acc (WBIO.L) and iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (BTEC.L). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

WBIO.L is traded in GBp, while BTEC.L is traded in USD. To make them comparable, the BTEC.L values have been converted to GBp using the latest available exchange rates.

Returns By Period

In the year-to-date period, WBIO.L achieves a 19.30% return, which is significantly higher than BTEC.L's 13.97% return.


WBIO.L

1D
-0.75%
1M
9.80%
6M
11.20%
YTD
19.30%
1Y
50.57%
3Y*
5.10%
5Y*
10Y*

BTEC.L

1D
0.00%
1M
7.86%
6M
11.73%
YTD
13.97%
1Y
47.71%
3Y*
15.40%
5Y*
6.09%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

WBIO.L vs. BTEC.L - Yearly Performance Comparison


2026 (YTD)20252024202320222021
WBIO.L
WisdomTree BioRevolution UCITS ETF USD Acc
19.30%13.58%-14.08%-5.86%-18.24%-2.00%
BTEC.L
iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
13.97%23.49%-0.33%0.91%-1.44%-1.70%

Correlation

The correlation between WBIO.L and BTEC.L is 0.82, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.82

Correlation (3Y)
Calculated over the trailing 3-year period

0.82

Correlation (All Time)
Calculated using the full available price history since Dec 9, 2021

0.83

The correlation between WBIO.L and BTEC.L has been stable across timeframes, ranging from 0.82 to 0.83 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

WBIO.L vs. BTEC.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WBIO.L
WBIO.L Risk / Return Rank: 7373
Overall Rank
WBIO.L Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
WBIO.L Sortino Ratio Rank: 7171
Sortino Ratio Rank
WBIO.L Omega Ratio Rank: 6363
Omega Ratio Rank
WBIO.L Calmar Ratio Rank: 9090
Calmar Ratio Rank
WBIO.L Martin Ratio Rank: 7070
Martin Ratio Rank

BTEC.L
BTEC.L Risk / Return Rank: 9090
Overall Rank
BTEC.L Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
BTEC.L Sortino Ratio Rank: 8989
Sortino Ratio Rank
BTEC.L Omega Ratio Rank: 8282
Omega Ratio Rank
BTEC.L Calmar Ratio Rank: 9595
Calmar Ratio Rank
BTEC.L Martin Ratio Rank: 9393
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WBIO.L vs. BTEC.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution UCITS ETF USD Acc (WBIO.L) and iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (BTEC.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


WBIO.LBTEC.LDifference
Sharpe ratioReturn per unit of total volatility

-0.42

Sortino ratioReturn per unit of downside risk

-0.58

Omega ratioGain probability vs. loss probability

1.31

1.37

-0.07

Calmar ratioReturn relative to maximum drawdown

4.38

6.45

-2.07

Martin ratioReturn relative to average drawdown

10.16

18.57

-8.40

WBIO.L vs. BTEC.L - Sharpe Ratio Comparison

The current WBIO.L Sharpe Ratio is 1.89, which is comparable to the BTEC.L Sharpe Ratio of 2.31. The chart below compares the historical Sharpe Ratios of WBIO.L and BTEC.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

WBIO.L vs. BTEC.L - Drawdown Comparison

The maximum WBIO.L drawdown since its inception was -51.13%, which is greater than BTEC.L's maximum drawdown of -31.02%. Use the drawdown chart below to compare losses from any high point for WBIO.L and BTEC.L.


Loading charts...

Drawdown Indicators


WBIO.LBTEC.LDifference

Max Drawdown

Largest peak-to-trough decline

-51.13%

-31.02%

-20.11%

Max Drawdown (1Y)

Largest decline over 1 year

-11.50%

-7.31%

-4.19%

Max Drawdown (3Y)

Largest decline over 3 years

-39.27%

-26.37%

-12.90%

Max Drawdown (5Y)

Largest decline over 5 years

-31.02%

Current Drawdown

Current decline from peak

-12.23%

-5.72%

-6.51%

Average Drawdown

Average peak-to-trough decline

-25.99%

-9.99%

-16.00%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.96%

2.54%

+2.42%

Volatility

WBIO.L vs. BTEC.L - Volatility Comparison

WisdomTree BioRevolution UCITS ETF USD Acc (WBIO.L) has a higher volatility of 7.80% compared to iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (BTEC.L) at 5.91%. This indicates that WBIO.L's price experiences larger fluctuations and is considered to be riskier than BTEC.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


WBIO.LBTEC.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.80%

5.91%

+1.89%

Volatility (6M)

Calculated over the trailing 6-month period

17.65%

15.31%

+2.34%

Volatility (1Y)

Calculated over the trailing 1-year period

26.72%

20.42%

+6.30%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

23.72%

20.98%

+2.74%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.72%

22.30%

+1.42%

WBIO.L vs. BTEC.L - Expense Ratio Comparison

WBIO.L has a 0.45% expense ratio, which is higher than BTEC.L's 0.35% expense ratio.


Dividends

WBIO.L vs. BTEC.L - Dividend Comparison

Neither WBIO.L nor BTEC.L has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


WBIO.L and BTEC.L have a correlation of 0.82, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, BTEC.L is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.

BTEC.L is cheaper with a 0.35% expense ratio, compared with 0.45% for WBIO.L.

WBIO.L tracks NASDAQ Biotechnology TR USD, while BTEC.L tracks NASDAQ Biotechnology NET Index. They also come from different issuers: WisdomTree and iShares. Their fees differ too: 0.45% for WBIO.L and 0.35% for BTEC.L.

Portfolio Optimizer

Find the right allocation for WBIO.L and BTEC.L

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer